NCT00116727已完成不适用
Rheumatoid Arthritis Disease Modifying Anti-Rheumatic Drug (DMARD) Intervention and Utilization Study (RADIUS 2)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Amgen
- 入组人数
- 5,103
研究概览
简要总结
To systematically collect and document use patterns, effectiveness and safety of DMARD treatments currently used in the management of rheumatoid arthritis. The primary purpose of this study is to estimate the incidence of serious adverse experiences and adverse experiences of interest in patients with rheumatoid arthritis (RA) treated with ENBREL®.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Fulfillment of the 1987 American Rheumatism Association criteria for RA
- •Currently requiring the addition of ENBREL® therapy (to be taken alone or in addition to their current DMARD therapy)
排除标准
- •Currently or previously enrolled in RADIUS 1
- •Currently enrolled in a clinical trial where treatments or patient visits are imposed by a protocol
- •Active infections
- •Known allergy to ENBREL® or any of its components
- •Current treatment with ENBREL®
- •Patients who have previously been demonstrated to be intolerant of or refractory to ENBREL® therapy
- •Nursing or pregnant women
研究组 & 干预措施
Drug
etanercept 50 mg/wk SC
干预措施: ENBREL® (Drug)
研究者
相似试验
已完成
不适用
Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudyRheumatoid ArthritisNCT00116714Amgen4,968
已完成
4 期
Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid ArthritisRheumatoid ArthritisNCT01881308Diakonhjemmet Hospital320
已完成
不适用
Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)Rheumatoid ArthritisNCT00724243Merck Sharp & Dohme LLC33
终止
不适用
Proactive Therapeutic Drug Monitoring Based Adalimumab Therapy Optimization in Patients With Rheumatoid ArthritisRheumatoid ArthritisNCT05460390Boston Medical Center5
已完成
不适用
Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)Rheumatoid ArthritisNCT01088321Bristol-Myers Squibb81,332